Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 May;32(5):642–645. doi: 10.1128/aac.32.5.642

In vitro susceptibility of Bacillus spp. to selected antimicrobial agents.

D J Weber 1, S M Saviteer 1, W A Rutala 1, C A Thomann 1
PMCID: PMC172245  PMID: 3395100

Abstract

Although often dismissed as contaminants when isolated from blood cultures, Bacillus spp. are increasingly recognized as capable of causing serious systemic infections. As part of a clinical-microbiological study, 89 strains of Bacillus spp. isolated from clinical blood cultures between 1981 and 1985 had their species determined and were tested for antimicrobial agent susceptibility to 18 antibiotics. Species of isolates were determined by the API 50CH and API 20E systems. Bacillus cereus (54 strains) was the most common species isolated, followed by B. megaterium (13 strains), B. polymyxa (5 strains), B. pumilus (4 strains), B. subtilis (4 strains), B. circulans (3 strains), B. amyloliquefaciens (2 strains), B. licheniformis (1 strain), and Bacillus spp. (3 strains). Microdilution MIC susceptibility tests revealed all B. cereus strains to be susceptible to imipenem, vancomycin, chloramphenicol, gentamicin, and ciprofloxacin. Non-B. cereus strains were most susceptible to imipenem, vancomycin, LY146032, and ciprofloxacin. Disk susceptibility testing suggested that B. cereus was rarely susceptible to penicillins, semisynthetic penicillins, or cephalosporins with the exception of mezlocillin. In contrast, many non-B. cereus strains were susceptible to penicillins, semisynthetic penicillins, and cephalosporins, but marked variability was noted among species.

Full text

PDF
642

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coonrod J. D., Leadley P. J., Eickhoff T. C. Antibiotic susceptibility of Bacillus species. J Infect Dis. 1971 Jan;123(1):102–105. doi: 10.1093/infdis/123.1.102. [DOI] [PubMed] [Google Scholar]
  2. Cotton D. J., Gill V. J., Marshall D. J., Gress J., Thaler M., Pizzo P. A. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol. 1987 Apr;25(4):672–674. doi: 10.1128/jcm.25.4.672-674.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davey R. T., Jr, Tauber W. B. Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection. Rev Infect Dis. 1987 Jan-Feb;9(1):110–123. doi: 10.1093/clinids/9.1.110. [DOI] [PubMed] [Google Scholar]
  4. FARRAR W. E., Jr Serious infections due to "non-pathogenic" organisms of the genus Bacillus. Review of their status as pathogens. Am J Med. 1963 Jan;34:134–141. doi: 10.1016/0002-9343(63)90047-0. [DOI] [PubMed] [Google Scholar]
  5. Ihde D. C., Armstrong D. Clinical spectrum of infection due to Bacillus species. Am J Med. 1973 Dec;55(6):839–845. doi: 10.1016/0002-9343(73)90266-0. [DOI] [PubMed] [Google Scholar]
  6. Logan N. A., Berkeley R. C. Identification of Bacillus strains using the API system. J Gen Microbiol. 1984 Jul;130(7):1871–1882. doi: 10.1099/00221287-130-7-1871. [DOI] [PubMed] [Google Scholar]
  7. O'Day D. M., Smith R. S., Gregg C. R., Turnbull P. C., Head W. S., Ives J. A., Ho P. C. The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981 Aug;88(8):833–838. doi: 10.1016/s0161-6420(81)34960-4. [DOI] [PubMed] [Google Scholar]
  8. Pearson H. E. Human infections caused by organisms of the bacillus species. Am J Clin Pathol. 1970 Apr;53(4):506–515. doi: 10.1093/ajcp/53.4.506. [DOI] [PubMed] [Google Scholar]
  9. Saleh R. A., Schorin M. A. Bacillus sp. sepsis associated with Hickman catheters in patients with neoplastic disease. Pediatr Infect Dis J. 1987 Sep;6(9):851–856. doi: 10.1097/00006454-198709000-00013. [DOI] [PubMed] [Google Scholar]
  10. Siegman-Igra Y., Lavochkin J., Schwartz D., Konforti N. Meningitis and bacteremia due to Bacillus cereus. A case report and a review of Bacillus infections. Isr J Med Sci. 1983 Jun;19(6):546–551. [PubMed] [Google Scholar]
  11. Sliman R., Rehm S., Shlaes D. M. Serious infections caused by Bacillus species. Medicine (Baltimore) 1987 May;66(3):218–223. doi: 10.1097/00005792-198705000-00005. [DOI] [PubMed] [Google Scholar]
  12. Tuazon C. U., Murray H. W., Levy C., Solny M. N., Curtin J. A., Sheagren J. N. Serious infections from Bacillus sp. JAMA. 1979 Mar 16;241(11):1137–1140. [PubMed] [Google Scholar]
  13. Turnbull P. C., Kramer J. M. Non-gastrointestinal Bacillus cereus infections: an analysis of exotoxin production by strains isolated over a two-year period. J Clin Pathol. 1983 Oct;36(10):1091–1096. doi: 10.1136/jcp.36.10.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wiedermann B. L. Non-anthrax Bacillus infections in children. Pediatr Infect Dis J. 1987 Feb;6(2):218–220. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES